APPLICATIONS PUBLISHED 4 DECEMBER 2002
Published: 1-May-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Improvements in or relating to the delivery of oral drugs
Vectura 1261316*
Methods and compsns for treating and preventing posterior segment ophthalmic disorders
Insite Vision 1261317*
Concentrated solution of quaternary ammonium compounds and methods of use
The University of Arkansas 1261318*
Lipid carrier
Lipocore 1261319*
Micellar pharmaceutical compsns for buccal and pulmonary application
Generex Pharmaceuticals 1261320*
Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
Boheringer Ingelheim Pharma 1261321*
Pharmaceutical compsns comprising an adenosine receptor agonist or antagonist
Can-Fite Biopharma 1261322*
Method of treating gastrointestinal tract disease with purinergic receptor agonists
Inspire Pharmaceuticals 1261323*
Tramadol for the treatment of functional gastrointestinal disorders
Euro-Celtique 1259324*
Nitroacridine/tumour inhibitor compsns
New York Medical College 1261325*
D-enantiomer for DFMO and methods of use therefore for treating cancer
Ilex Oncology 1261326*
Adenosine receptor modulators
F Hoffmann-La Roche 1261327*
IL-8 receptor antagonists
SmithKline Beecham 1261328*
IL-8 receptor antagonists
SmithKline Beecham 1261329*
Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
Hill's Pet Nutrition 1261330*
Method and compsns for treating fibrotic diseases
University of Nebraska Medical Center 1261331*
Use of CYP1B1 inhibitors for treating cancer
The University Court of the University of Aberdeen 1261332*
Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
Hedner, Jan; Grote, Ludger; Sjoestroem, Lars; Stenloef, Kaj 1261333*
Irrigation solution containing MAPK inhibitors and their use for treating pain and inflammation
Omeros Corp 1261334*
Brain, spinal and nerve injury treatment
F Hoffmann-La Roche 1261335*
IL-8 receptor antagonists
SmithKline Beecham 1261336*
Compsns and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
The University of British Columbia 1261337*
Compsns and methods for the treatment of epilepsy
Cymar 1261338*
Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
Pharmacia 1261339*
Compsns and methods for the treatment of Parkinson's disease
Alpha Research Group 1261340*
Farnesyl protein transferase inhibitor compounds with camptothecin compounds
Janssen Pharmaceutica 1261341*
Farnesyl protein transferase inhibitor combinations
Janssen Pharmaceutica 1261342*
Farnesyl protein transferase inhibitor combinations with anti-tumour nucleoside derivatives
Janssen Pharmaceutica 1261343*
Use of a compound for preparing a drug
Lundblad, Leif 1261344*
Herbal supplement for cognitive related impairment due to estrogen loss
Groce, Tricia 1261345*
Modulation of cardiovascular injury
The Rockefeller University 1261346*
Therapeutic compsns and methods for treating periodontitis with anti-inflammatory compounds
Rutgers, the State University of New Jersey 1261347*
Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents
Janssen Pharmaceutica 1261348*
Compounds with chelation affinity and selectivity for first transition series elements and their use
Concat 1261349*
Methods for synthesising 2-chloro-9-(2-deoxy-2-fluoro-(b)-D-arabino-furanosyl)-9H-purin-6-amine
Southern Research Institute 1261350*
Nystatin formulation having reduced toxicity
Wisconsin Alumni Research Foundation 1261351*
Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
Dynavax Technologies Corp 1261352*
Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
Dynavax Technologies Corp 1261353*
Delivery system and methods for gene therapy
Safescience 1261354*
Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
Societe des Produits Nestle 1261355*
Farnesyl protein transferase inhibitor combinations with platinum compounds
Janssen Pharmaceutica 1261356*
Isolation and transplantation of retinal stem cells
The Schepens Eye Research Institute 1261357*
Use of a compsn
Gidlund, Bo 1261358*
An improved herbal compsn having antiallergic properties and a process for the preparation thereof
Natural Remedies Private Ltd 1261359*
Casein derived proteins and uses thereof in therapy
Chay 13 Medical Research Group 1261360*
Oral, nasal and pulmonary dosage formulations of copolymer 1
Yeda Research and Development 1261361*
Novel amino acid and peptide inhibitors of Staphylococcus virulence
Intermune 1261362*
Methods for treating FSH related conditions with GNRH antagonists
Praecis Pharmaceuticals; Amgen 1261363*
Method of treating or inhibiting cellular injury or cell death
Wyeth 1261364*
Adjuvant treatment by in vivo activation of dendritic cells
The Board of Trustees of the Leland Stanford Junior University 1261366*
Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
Sigma-Tau Industrie Farmaceutiche Riunite 1261367*
Lipase-containing compsn and methods of use thereof
Altus Biologics 1261368*
Compsns and methods for tumour-targeted delivery of effector molecules
Vion Pharmaceuticals 1261369*
Therapeutic method for reducing angiogenesis
Sunnybrook Health Science 261370*
